Clinical Trial Update: Study of Fludarabine Based Conditioning for Allogeneic Stem Cell Transplantation for Myelofibrosis [Phase 2]

View source ↗

Summary

A Phase 2 study evaluated a fludarabine-based conditioning regimen before allogeneic stem cell transplantation in myelofibrosis, with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelofibrosis

Drugs mentioned

• Fludarabine (Fludarabine)

Snippet

Sponsor: John Mascarenhas | Conditions: Myelofibrosis | Phase 2 | Status: COMPLETED | Results posted: 2016-05-02